SCHEMBL17992215

SCHEMBL17992215

CCS(=O)(=O)/C=C(\N)c1ccc(OCC(F)(F)C(F)F)cn1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 5/20 0.39
▸ BACE2 Q9Y5Z0 3/20 0.39
▸ HTT P42858 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ ACACB O00763 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ SCN9A Q15858 6/20 0.33
▸ CTSD P07339 2/20 0.33
▸ CFTR P13569 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ MMP13 P45452 1/20 0.32
▸ MMP14 P50281 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19767082 0.88 ACACB (0.32) BACE1BACE2KMT2AACACBSCN9A
SCHEMBL17992211 0.86 BACE1 (0.37) BACE1BACE2KMT2AUSP2MAPT
SCHEMBL18811649 0.81 BACE1 (0.38) BACE1BACE2HTTKMT2ASMN1; SMN2
SCHEMBL17992189 0.77 KMT2A (0.41) BACE1BACE2HTTKMT2ASMN1; SMN2
SCHEMBL1974946 0.75 P4HTM (0.52) BACE1BACE2HTTKMT2ASMN1; SMN2
SCHEMBL15669996 0.75 KMT2A (0.44) BACE1BACE2HTTKMT2ASMN1; SMN2
SCHEMBL1973974 0.74 KMT2A (0.48) BACE1BACE2HTTKMT2ASMN1; SMN2
SCHEMBL17668770 0.74 KMT2A (0.47) BACE1BACE2HTTKMT2ASMN1; SMN2
SCHEMBL19672945 0.72 HTT (0.41) BACE1BACE2HTTKMT2ASMN1; SMN2
SCHEMBL28749827 0.69 HTT (0.43) BACE1BACE2HTTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10173997-B2 Bipyridine compound and use of same for noxious arthropod control SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-01-08 — — US disclosed
US-20180009778-A1 BIPYRIDINE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-01-11 — — US disclosed
WO-2017073733-A1 PEST CONTROL COMPOSITION AND USE THEREOF 住友化学株式会社 2017-05-04 — — WO disclosed
WO-2016121969-A1 BIPYRIDINE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL 住友化学株式会社 2016-08-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180009778-A1 BIPYRIDINE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL BBOX1, ACHE, MORF4L1 BACE1 4378/4885BACE2 3701/4885HTT 4092/4885
US-10173997-B2 Bipyridine compound and use of same for noxious arthropod control BBOX1, ACHE, MORF4L1 BACE1 4378/4885BACE2 3701/4885HTT 4092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback